Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC 4.0Journal of Pain Research

Effects of Heat-Conduction Dry Needling on Pain and Physical Function in Early-to-Mid-Stage Knee Osteoarthritis: A Randomized Controlled Trial with 12-Month Follow-Up

  1. 1Department of Rehabilitation Medicine, Ningxia Medical University General Hospital, Yinchuan, Ningxia Hui Autonomous Region, People’s Republic of China
  2. 2Department of Rehabilitation Medicine, Ningxia Integrated Traditional Chinese and Western Medicine Hospital, Yinchuan, Ningxia Hui Autonomous Region, People’s Republic of China

Abstract

Purpose: To compare the 12-month effects of heat-conduction dry needling (HCDN) and transcutaneous electrical nerve stimulation (TENS) on pain and physical function in early-to-mid-stage knee osteoarthritis (KOA).

Patients and Methods: In this single-center, parallel-group randomized clinical trial, 47 participants were allocated to HCDN (n=24) or TENS (n=23) for 4 weeks. Primary outcomes were WOMAC total and subscale scores; numerical rating scale (NRS) pain was prespecified. Secondary outcomes were 30-second Chair Stand Test, safety, and exploratory MRI cartilage volume. Seven participants had baseline data only. Fifty multiply imputed datasets were generated by chained equations with predictive mean matching. Linear mixed-effects models included group, categorical time, and group-by-time fixed effects and a participant-specific random intercept; estimates were pooled by Rubin’s rules.

Results: Group-by-time interactions were significant for NRS pain (pooled Wald χ2[4]=13.48, P=0.009), WOMAC pain (χ2[4]=46.97, P<0.001), WOMAC total (χ2[4]=46.68, P<0.001), and WOMAC activities of daily living (χ2[4]=40.41, P<0.001). At 12 months, HCDN–TENS differences were −1.58 points for NRS pain (95% CI −2.36 to −0.79; Holm-adjusted P<0.001) and −3.70 points for WOMAC pain (95% CI −5.01 to −2.38; Holm-adjusted P<0.001). A ≥50% NRS reduction occurred in 69.8% of HCDN and 27.3% of TENS participants (risk ratio 2.58, 95% CI 1.17–5.65). No serious adverse events occurred.

Conclusion: HCDN was associated with more sustained reductions in pain and improvements in patient-reported function than TENS. Larger multicenter trials with sham or usual-care comparators are required.

Related

  1. Effects of Chondroitin Sulfate on Joint Symptoms and Physical Function in Adults with Mild Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial
    Hyang-Im Baek, Soo Jung Park
    NutrientsPeer-reviewedCC BY 4.0Full textNutritionCrossrefEurope PMC
  2. Penetrating needling from Qiuxu (GB40) to Zhaohai (KI6) versus separate needling for post-stroke lower-limb motor dysfunction: an assessor-blinded randomized controlled trial protocol
    Jie Zhang, Lin Wang, Zhen Tian +8
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textNeurologyCrossrefPMC
  3. Electroacupuncture Combined with Surround Needling for Acute Lateral Ankle Sprain in Adults: A Randomized Controlled Trial.
    Qimiao Hu, Qingzi Cai, Bonuo Qi +4
    Journal of pain researchPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Intradermal thumbtack needling as an adjunctive therapy for sepsis-induced gastrointestinal dysfunction: A pilot randomized controlled trial
    Tingting Liu, Jiatian Ma, Ying Qiu +2
    Journal of traditional and complementary medicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  5. Effects on deep dry needling of the TIBIALIS posterior muscle on plantar pressure distribution: A single-blinded randomized controlled baropodometric trial
    María Carmen Martínez-González, Sonia del-Río-Medina, Sergio Montero-Navarro +8
    PLOS OnePeer-reviewedCC BY 4.0Full textPhysiologyPLOS
BibTeX
@article{lian2026effects,
  title = {{Effects of Heat-Conduction Dry Needling on Pain and Physical Function in Early-to-Mid-Stage Knee Osteoarthritis: A Randomized Controlled Trial with 12-Month Follow-Up}},
  author = {Jiawei Lian and Weidong Jin and Shiqiang Zhu and Menglai Hao and Yindi Bai and Bojun Wen and Furong Liu and Xinyi Wang and Jinchen Zhang and Ruizhu Lin and Jianfeng Xu},
  journal = {Journal of Pain Research},
  year = {2026},
  month = oct,
  doi = {10.2147/jpr.s630783},
  url = {https://doi.org/10.2147/jpr.s630783},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Effects of Heat-Conduction Dry Needling on Pain and Physical Function in Early-to-Mid-Stage Knee Osteoarthritis: A Randomized Controlled Trial with 12-Month Follow-Up
AU  - Jiawei Lian
AU  - Weidong Jin
AU  - Shiqiang Zhu
AU  - Menglai Hao
AU  - Yindi Bai
AU  - Bojun Wen
AU  - Furong Liu
AU  - Xinyi Wang
AU  - Jinchen Zhang
AU  - Ruizhu Lin
AU  - Jianfeng Xu
PY  - 2026
DA  - 2026/10/30
JO  - Journal of Pain Research
DO  - 10.2147/jpr.s630783
UR  - https://doi.org/10.2147/jpr.s630783
AB  - Purpose: To compare the 12-month effects of heat-conduction dry needling (HCDN) and transcutaneous electrical nerve stimulation (TENS) on pain and physical function in early-to-mid-stage knee osteoarthritis (KOA).  Patients and Methods: In this single-center, parallel-group randomized clinical trial, 47 participants were allocated to HCDN (n=24) or TENS (n=23) for 4 weeks. Primary outcomes were WOMAC total and subscale scores; numerical rating scale (NRS) pain was prespecified. Secondary outcomes were 30-second Chair Stand Test, safety, and exploratory MRI cartilage volume. Seven participants had baseline data only. Fifty multiply imputed datasets were generated by chained equations with predictive mean matching. Linear mixed-effects models included group, categorical time, and group-by-time fixed effects and a participant-specific random intercept; estimates were pooled by Rubin’s rules.  Results: Group-by-time interactions were significant for NRS pain (pooled Wald χ2[4]=13.48, P=0.009), WOMAC pain (χ2[4]=46.97, P<0.001), WOMAC total (χ2[4]=46.68, P<0.001), and WOMAC activities of daily living (χ2[4]=40.41, P<0.001). At 12 months, HCDN–TENS differences were −1.58 points for NRS pain (95% CI −2.36 to −0.79; Holm-adjusted P<0.001) and −3.70 points for WOMAC pain (95% CI −5.01 to −2.38; Holm-adjusted P<0.001). A ≥50% NRS reduction occurred in 69.8% of HCDN and 27.3% of TENS participants (risk ratio 2.58, 95% CI 1.17–5.65). No serious adverse events occurred.  Conclusion: HCDN was associated with more sustained reductions in pain and improvements in patient-reported function than TENS. Larger multicenter trials with sham or usual-care comparators are required.
SN  - 1178-7090
ER  -